Updated results of the placebo‐controlled, phase III JAKARTA trial of fedratinib in patients with intermediate‐2 or high‐risk myelofibrosis

Pardanani, Animesh ✉; Tefferi, Ayalew; Masszi, Tamás [Masszi, Tamás (Belgyógyászat, ha...), author] Belgyógyászati és Hematológiai Klinika (SU / FM / C); Mishchenko, Elena; Drummond, Mark; Jourdan, Eric; Vannucchi, Alessandro; Jurgutis, Mindaugas; Ribrag, Vincent; Rambaldi, Alessandro; Koh, Liang Piu; Rose, Shelonitda; Zhang, Jun; Harrison, Claire